In utero exposure to selective serotonin reuptake inhibitors and risk for autism spectrum disorder

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

In utero exposure to selective serotonin reuptake inhibitors and risk for autism spectrum disorder. / Gidaya, Nicole B; Lee, Brian K; Burstyn, Igor; Yudell, Michael; Mortensen, Erik L; Newschaffer, Craig J.

In: Journal of Autism and Developmental Disorders, Vol. 44, No. 10, 10.2014, p. 2558-67.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Gidaya, NB, Lee, BK, Burstyn, I, Yudell, M, Mortensen, EL & Newschaffer, CJ 2014, 'In utero exposure to selective serotonin reuptake inhibitors and risk for autism spectrum disorder', Journal of Autism and Developmental Disorders, vol. 44, no. 10, pp. 2558-67. https://doi.org/10.1007/s10803-014-2128-4

APA

Gidaya, N. B., Lee, B. K., Burstyn, I., Yudell, M., Mortensen, E. L., & Newschaffer, C. J. (2014). In utero exposure to selective serotonin reuptake inhibitors and risk for autism spectrum disorder. Journal of Autism and Developmental Disorders, 44(10), 2558-67. https://doi.org/10.1007/s10803-014-2128-4

Vancouver

Gidaya NB, Lee BK, Burstyn I, Yudell M, Mortensen EL, Newschaffer CJ. In utero exposure to selective serotonin reuptake inhibitors and risk for autism spectrum disorder. Journal of Autism and Developmental Disorders. 2014 Oct;44(10):2558-67. https://doi.org/10.1007/s10803-014-2128-4

Author

Gidaya, Nicole B ; Lee, Brian K ; Burstyn, Igor ; Yudell, Michael ; Mortensen, Erik L ; Newschaffer, Craig J. / In utero exposure to selective serotonin reuptake inhibitors and risk for autism spectrum disorder. In: Journal of Autism and Developmental Disorders. 2014 ; Vol. 44, No. 10. pp. 2558-67.

Bibtex

@article{f71fd599a7b84f8cbe96c0148cb32862,
title = "In utero exposure to selective serotonin reuptake inhibitors and risk for autism spectrum disorder",
abstract = "We investigated whether there is an association between increased risk for autism spectrum disorders (ASD) and selective serotonin reuptake inhibitors (SSRIs) used during pregnancy. This study used Denmark's health and population registers to obtain information regarding prescription drugs, ASD diagnosis, and health and socioeconomic status. There were 1.5 {\%} of cases and 0.7 {\%} of controls exposed to SSRIs during the pregnancy period, and higher effect estimates observed with longer use. We found evidence that in utero exposure to SSRIs increases a child's risk associated with ASD. These results, while adding to the limited knowledge on prenatal pharmacological exposures as potential ASD risk factors, need to be balanced against the benefits of indicated medication use by pregnant mothers.",
author = "Gidaya, {Nicole B} and Lee, {Brian K} and Igor Burstyn and Michael Yudell and Mortensen, {Erik L} and Newschaffer, {Craig J}",
year = "2014",
month = "10",
doi = "10.1007/s10803-014-2128-4",
language = "English",
volume = "44",
pages = "2558--67",
journal = "Journal of Autism and Developmental Disorders",
issn = "0162-3257",
publisher = "Springer",
number = "10",

}

RIS

TY - JOUR

T1 - In utero exposure to selective serotonin reuptake inhibitors and risk for autism spectrum disorder

AU - Gidaya, Nicole B

AU - Lee, Brian K

AU - Burstyn, Igor

AU - Yudell, Michael

AU - Mortensen, Erik L

AU - Newschaffer, Craig J

PY - 2014/10

Y1 - 2014/10

N2 - We investigated whether there is an association between increased risk for autism spectrum disorders (ASD) and selective serotonin reuptake inhibitors (SSRIs) used during pregnancy. This study used Denmark's health and population registers to obtain information regarding prescription drugs, ASD diagnosis, and health and socioeconomic status. There were 1.5 % of cases and 0.7 % of controls exposed to SSRIs during the pregnancy period, and higher effect estimates observed with longer use. We found evidence that in utero exposure to SSRIs increases a child's risk associated with ASD. These results, while adding to the limited knowledge on prenatal pharmacological exposures as potential ASD risk factors, need to be balanced against the benefits of indicated medication use by pregnant mothers.

AB - We investigated whether there is an association between increased risk for autism spectrum disorders (ASD) and selective serotonin reuptake inhibitors (SSRIs) used during pregnancy. This study used Denmark's health and population registers to obtain information regarding prescription drugs, ASD diagnosis, and health and socioeconomic status. There were 1.5 % of cases and 0.7 % of controls exposed to SSRIs during the pregnancy period, and higher effect estimates observed with longer use. We found evidence that in utero exposure to SSRIs increases a child's risk associated with ASD. These results, while adding to the limited knowledge on prenatal pharmacological exposures as potential ASD risk factors, need to be balanced against the benefits of indicated medication use by pregnant mothers.

U2 - 10.1007/s10803-014-2128-4

DO - 10.1007/s10803-014-2128-4

M3 - Journal article

VL - 44

SP - 2558

EP - 2567

JO - Journal of Autism and Developmental Disorders

JF - Journal of Autism and Developmental Disorders

SN - 0162-3257

IS - 10

ER -

ID: 123992872